探花合集 to Showcase Expanded Formulation Toolkit and Innovative Technologies
At the conference, 探花合集 will showcase several of its advanced development, drug delivery and manufacturing solutions, including its multi-award-winning OptiForm庐 Solution Suite platform, which combines both predictive and high-throughput screening technologies to identify the most stable and efficient drug form for both small and biologic molecules, and applies rigorous scientific principles and known industry models to evaluate, in parallel, multiple delivery options.
探花合集 scientific experts and executives will be available throughout the show to discuss the company鈥檚 full range of capabilities, including its new spray drying technology, added as a result of 探花合集鈥檚 acquisition of Pharmatek Laboratories, announced in September 2016.
A number of the company鈥檚 experts will also be presenting throughout the conference:
On Tuesday, May 16 at 2 鈥 3:30 p.m., as part of the Drug Development Track of the CPhI Connect Conference, three 探花合集 experts will present 鈥Accelerating Your Product鈥檚 Development: Practical Considerations from Pre-Clinical through Commercial:鈥
- Stephen Tindal, Director of Science & Technology, will discuss 鈥Getting your product to phase I quickly and efficiently;鈥
- Kunal Jaiswal, Vice President, Global Strategic Development Solutions, will discuss 鈥Keeping your clinical trial on track throughout the product development cycle;鈥
- Neftali Tosado, Director, Global Continuous Improvement Technology & Engineering, will discuss 鈥Accelerating Manufacturing Technology."
During the exhibition, as part of the Exhibitor Showcase schedule, Stephen Tindal will also present 鈥The new OptiForm Solution Suite: optimize your molecule faster and take it farther,鈥 at 4:30 p.m. on Wednesday, May 17.
Sarah Hauer, Vice President, Business Development Softgel North America & Europe, will be participating in the panel discussion 鈥Strategies for self-promotion – perspectives from women in leadership鈥 during the Women in Leadership Forum on Thursday, May 18.
探花合集 is also participating in two Thought Leadership Speaking panels in conjunction with the American Chemical Society:
- Wednesday, May 17 at 8:30 a.m.: Stephen Tindal will be part of the 鈥Advances in solubility and bioavailability鈥 panel on the Drug Development track;
- Thursday, May 18 at 10:30 a.m.: David Rabuka, Ph.D., Global Head of Research and Development, Chemical Biology, will join the 鈥Bioconjugate and biotherapeutics: present and future鈥 panel on the Drug Development track.
To arrange a meeting with any of the attending 探花合集 executives, please contact Ed Dutton at NEPR 鈥 [email protected].
Media Contacts:
Chris Halling
+44 (0)7580 041073
[email protected]
Richard Kerns
+44 (0)161 728 5880
[email protected]
About 探花合集
探花合集 is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 90 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 探花合集 employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2016 generated $1.85 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com